Ginkgo Bioworks Holdings Inc.
Organization details
- Legal name
- Ginkgo Bioworks Holdings Inc.
- Former names
- Soaring Eagle Acquisition Corp. Spinning Eagle Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DNA
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001830214
- EIN
- 87-2652913
- Wikidata ID
- Q29026065
Board of directors
-
Arie Belldegrun · DirectorSince 2023
-
Christian O. Henry · DirectorSince 2023
- Since 2023
-
Jason R. Kelly · Director · See remarksSince 2023
-
Kathy Hopinkah Hannan · DirectorSince 2023
-
Marijn E. Dekkers · DirectorSince 2023
-
Myrtle S. Potter · DirectorSince 2024
-
Reshma Kewalramani · DirectorSince 2023
-
Reshma P. Shetty · Director · See remarksSince 2023
-
Ross Fubini · DirectorSince 2024
-
Shyam Sankar · DirectorSince 2023
-
Sri Kosuri · DirectorSince 2024
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.2%
Board connections
6 of this board's directors also sit on 13 other boards. 5 are in the same sector.
-
Allogene Therapeutics Inc. Same sectorvia Arie Belldegrun
- via Kathy Hopinkah Hannan
- via Harry Sloan
- via Kathy Hopinkah Hannan
- via Harry Sloan
-
Guardant Health Inc. Same sectorvia Myrtle S. Potter
- via Harry Sloan
- via Harry Sloan
- via Kathy Hopinkah Hannan
- via Harry Sloan
-
UroGen Pharma Ltd. Same sectorvia Arie Belldegrun
-
Vertex Pharmaceuticals Incorporated Same sectorvia Reshma Kewalramani
-
Wave Life Sciences Inc. Same sectorvia Christian O. Henry
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,952,796
- 24 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | Canton Barry 10% owner | Open-market sale | −18,803 | $10.14 | $190,719 |
| Oct 19, 2026 | Coen Steven P. Officer (See remarks) | Open-market sale | −766 | $10.14 | $7,770 |
| Oct 19, 2026 | Jason R. Kelly Director, Officer (See remarks) | Open-market sale | −45,682 | $10.14 | $463,353 |
| Oct 19, 2026 | Reshma P. Shetty Director, Officer (See remarks), 10% owner | Open-market sale | −22,369 | $10.14 | $226,889 |
| Oct 19, 2026 | Canton Barry 10% owner | Open-market sale | −22,369 | $10.14 | $226,889 |
| Oct 19, 2026 | Reshma P. Shetty Director, Officer (See remarks), 10% owner | Open-market sale | −18,803 | $10.14 | $190,719 |
| Oct 16, 2026 | Canton Barry 10% owner | Option exercise | +26,802 | — | — |
| Oct 16, 2026 | Coen Steven P. Officer (See remarks) | Option exercise | +1,174 | — | — |
| Oct 16, 2026 | Jason R. Kelly Director, Officer (See remarks) | Option exercise | +55,694 | — | — |
| Oct 16, 2026 | Reshma P. Shetty Director, Officer (See remarks), 10% owner | Option exercise | +29,279 | — | — |
| Oct 16, 2026 | Canton Barry 10% owner | Option exercise | +9,762 | — | — |
| Oct 16, 2026 | Coen Steven P. Officer (See remarks) | Option exercise | +312 | — | — |
| Oct 16, 2026 | Jason R. Kelly Director, Officer (See remarks) | Option exercise | +25,790 | — | — |
| Oct 16, 2026 | Reshma P. Shetty Director, Officer (See remarks), 10% owner | Option exercise | +10,619 | — | — |
| Oct 16, 2026 | Canton Barry 10% owner | Option exercise | +29,279 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Ginkgo Bioworks Holdings Inc.
How many directors are on Ginkgo Bioworks Holdings Inc.'s board?
Ginkgo Bioworks Holdings Inc.'s board has 12 directors: Arie Belldegrun, Christian O. Henry, Harry Sloan, Jason R. Kelly, Kathy Hopinkah Hannan, Marijn E. Dekkers, Myrtle S. Potter, Reshma Kewalramani, Reshma P. Shetty, Ross Fubini and 2 others.
Are Ginkgo Bioworks Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Ginkgo Bioworks Holdings Inc. insiders made no open-market purchases and sold $5.0 million of shares in 24 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="ginkgo-bioworks-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.